IL6 and pancreatic neoplasm: Interleukin-6 (IL-6), a vital inflammation-related cytokine that is enhanced by hypoxia and K-ras, and in turn contributes to the formation of the tumor microenvironment, has been implicated in pancreatic cancer angiogenesis and metastasis [3].